Future Journal of Pharmaceutical Sciences is affiliated with Future University in Egypt.
Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach
Lung cancer remains the leading and deadly type of cancer worldwide. It was estimated to account for about 25% of the 7 million people that died as a result of cancer-related issues/mortality every year in the...
Citation: Future Journal of Pharmaceutical Sciences 2021 7:140